Planning to open manufacturing facility in Russia soon: Trivitron Group CEO

Apart from our joint venture in Russia, we are investing heavily in the US, where we already have infrastructure, including factories and R&D setups, said Ganjoo

Chennai-headquartered Trivitron Healthcare, makers of medical technology products like point of care testing devices and radiography solutions, has presence in the US, China and Europe apart from India. The company is now eyeing a manufacturing base in Russia soon. Chandra Ganjoo, group chief executive officer (group CEO), in a telephonic conversation with Anjali Singh in Mumbai, revealed the company’s expansion and investment plans. Edited excerpts: 

Are there any plans to open manufacturing facilities outside India?

We already have facilities in the US, Europe and China. From a manufacturing point of view, the immediate venture is coming up in Russia. To be a manufacturer in Russia, you can’t be present as a sole foreign company. You have to collaborate with a local partner. So, our investment in a joint venture would be 50 per cent each and we can see that happening in two months. With that, we will more or less cover the entire globe from the manufacturing point.

What are your investment plans this year? 

Apart from our joint venture in Russia, we are investing big in the US, where we already have infrastructure like factories and research and development (R&D) setups. In India, there are some greenfield initiatives happening. We are in talks with a few companies, mostly in the consumables segment. We are planning to buy them out. So, I think a couple of exciting things are going to happen in the next four-five months.

Is Trivitron Healthcare planning to add more tests or devices in its portfolio?

Yes, we are. The trend in healthcare is going from basic to high-tech now. This is especially true for us, since we have already covered the basic part of healthcare. Now, we are getting into high-end technologies. Our first Make in India CT Scan is already there. We are just waiting for regulatory approval and plan to launch it in the country in a couple of months. We are also talking about introducing our cath lab in India. It will be a high technology-based equipment laboratory.

What is Trivitron’s perspective on the recently introduced National Medical Devices Policy 2023?

There has been a lot of noise made by Indian manufacturers, who want changes in this policy. Many representations have been made to the government. I think there is a discussion happening with the government on some changes in the policy. When you talk about made in India and made for India by international companies, there is a difference.